Vivos Therapeutics (VVOS) Cash from Operations (2020 - 2026)
Vivos Therapeutics (VVOS) reported Cash from Operations of 6010000.0 for Q1 2026, down 58.32% year-over-year from 14420960.81 in Q1 2025, and down 59.71% on a QoQ basis from 3763000.0 in Q4 2025.
Vivos Therapeutics (VVOS) has 7 years of Cash from Operations data on file, last reported at 6010000.0 in Q1 2026.
- Quarterly Cash from Operations fell 58.32% year-over-year to 6010000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17477000.0 (down 25.09% YoY) and the FY2025 annual result came in at 15263000.0, down 20.27% from the prior year.
- Cash from Operations slipped to 6010000.0 in Q1 2026 per VVOS's latest filing, from 3763000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 2516000.0 in Q1 2024 and bottomed at 6100000.0 in Q1 2022.
- The 5-year median for Cash from Operations is 3504000.0 (2025), against an average of 3850058.82.
- The widest annual swing landed in 2023, when Cash from Operations soared 52.54%; it then tumbled 58.32% in 2026.
- Tracing VVOS's Cash from Operations over 5 years: stood at 2987000.0 in 2022, then gained by 9.61% to 2700000.0 in 2023, then slipped by 8.89% to 2940000.0 in 2024, then decreased by 27.99% to 3763000.0 in 2025, then slumped by 59.71% to 6010000.0 in 2026.
- Per Business Quant, the three latest VVOS Cash from Operations figures stand at 6010000.0 (Q1 2026), 3763000.0 (Q4 2025), and 4200000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.74 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 220.10 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 525.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 335.40 Mn |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | -6.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.01 Mn |
| Mar 31, 2026 | -6.01 Mn |
| Dec 31, 2025 | -3.76 Mn |
| Dec 31, 2025 | -3.76 Mn |
| Sep 30, 2025 | -4.20 Mn |
| Sep 30, 2025 | -4.20 Mn |
| Jun 30, 2025 | -3.50 Mn |
| Jun 30, 2025 | -3.50 Mn |
| Mar 31, 2025 | -3.80 Mn |
| Mar 31, 2025 | -3.80 Mn |
| Dec 31, 2024 | -2.90 Mn |
| Dec 31, 2024 | -2.90 Mn |
| Sep 30, 2024 | -4.20 Mn |
| Sep 30, 2024 | -4.20 Mn |
| Jun 30, 2024 | -3.10 Mn |
| Jun 30, 2024 | -3.10 Mn |
| Mar 31, 2024 | -2.50 Mn |
| Mar 31, 2024 | -2.50 Mn |
| Dec 31, 2023 | -2.70 Mn |
| Dec 31, 2023 | -2.70 Mn |
| Sep 30, 2023 | -2.80 Mn |
| Sep 30, 2023 | -2.80 Mn |
| Jun 30, 2023 | -2.86 Mn |
| Jun 30, 2023 | -2.86 Mn |
| Mar 31, 2023 | -3.54 Mn |
| Mar 31, 2023 | -3.54 Mn |
| Dec 31, 2022 | -3.00 Mn |
| Dec 31, 2022 | -3.00 Mn |
| Sep 30, 2022 | -5.90 Mn |
| Sep 30, 2022 | -5.90 Mn |
| Jun 30, 2022 | -4.60 Mn |
| Jun 30, 2022 | -4.60 Mn |
| Mar 31, 2022 | -6.10 Mn |
| Mar 31, 2022 | -6.10 Mn |
| Dec 31, 2021 | -4.12 Mn |
| Dec 31, 2021 | -4.12 Mn |
| Sep 30, 2021 | -4.06 Mn |
| Sep 30, 2021 | -4.06 Mn |
| Jun 30, 2021 | -3.66 Mn |
| Jun 30, 2021 | -3.66 Mn |
| Mar 31, 2021 | -3.90 Mn |
| Mar 31, 2021 | -3.90 Mn |
| Dec 31, 2020 | -3.64 Mn |
| Dec 31, 2020 | -3.64 Mn |
| Sep 30, 2020 | -674,441.00 |
| Sep 30, 2020 | -674,441.00 |
| Jun 30, 2020 | -950,597.00 |
| Jun 30, 2020 | -950,597.00 |
| Mar 31, 2020 | -436,910.00 |
| Mar 31, 2020 | -436,910.00 |